Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum [17]

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 1052-1053

  Ghislain, P D ^a   De Decker, I ^a   Marot, L ^a   Lachapelle, J M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; BLOOD; OINTMENT;

AGED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; PYODERMA GANGRENOSUM; TACROLIMUS;

EID: 3042783277     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05914.x     Document Type: Letter

References (6)

1. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dematol Venereol 2002; 16: 100-14.
2. Allen DM. Esterly NB. Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol 2002; 138: 1259-60.
3. Allen A, Siegfried E, Silverman R et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137: 747-50.
4. Klein IH, Abrahams A, van Ede T et al. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002; 73: 732-6.
5. Jain AB, Venkataramanan R, Fung J et al. Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK506. Transplant Proc 1991; 23: 2777-9.
6. Russell RK, Richardson N, Wilson DC. Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. J Pediatr Gastroenterol Nutr 2001; 32: 207-8.